World News

ESMO Shares Recommendations to Support Cancer Research and Clinical Trials in...

Ogkologos - 28 Μαΐου, 2026

FDA Grants Accelerated Approval to Sonrotoclax for Relapsed or Refractory Mantle...

Ogkologos - 27 Μαΐου, 2026

Ahead of key Competitiveness Council Meeting of European Research Ministers, ESMO...

Ogkologos - 26 Μαΐου, 2026

Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context

Ogkologos - 22 Μαΐου, 2026

EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib

Ogkologos - 22 Μαΐου, 2026

ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk...

Ogkologos - 21 Μαΐου, 2026

FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma

Ogkologos - 20 Μαΐου, 2026

Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for...

Ogkologos - 19 Μαΐου, 2026

ESMO Advocates for Equal Access to Optimal Cancer Care for all...

Ogkologos - 18 Μαΐου, 2026

Additional Translations of the ESMO Patient Guides Now Available in the Croatian

Ogkologos - 18 Μαΐου, 2026

1...161718...432 Σελίδα 17 από 432

MOST POPULAR

EMA Recommends Extension of Indications for Osimertinib

18 Δεκεμβρίου, 2024

Reflections from our chief scientist: The rise of the whole organism

4 Φεβρουαρίου, 2022

FDA Approves Ribociclib with an Aromatase Inhibitor and Ribociclib and Letrozole...

28 Οκτωβρίου, 2024

More Immunotherapy Options Approved for Treating Endometrial Cancer

6 Αυγούστου, 2024

Φόρτωση περισσοτέρων

ESMO Shares Recommendations to Support Cancer Research and Clinical Trials in...

FDA Grants Accelerated Approval to Sonrotoclax for Relapsed or Refractory Mantle...

Ahead of key Competitiveness Council Meeting of European Research Ministers, ESMO...

Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context

EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib

ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk...

FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma

Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for...

ESMO Advocates for Equal Access to Optimal Cancer Care for all...

Additional Translations of the ESMO Patient Guides Now Available in the Croatian

MOST POPULAR

EMA Recommends Extension of Indications for Osimertinib

Reflections from our chief scientist: The rise of the whole organism

FDA Approves Ribociclib with an Aromatase Inhibitor and Ribociclib and Letrozole...

More Immunotherapy Options Approved for Treating Endometrial Cancer

HOT NEWS

Great Oaks Grow From Small Acorns Oncology Is Committed to Doing...

EMA Adopts a Positive Opinion for a New Route of Administration...

How Finding the Right Primary Care Physician During Cancer Has Helped...

Epigenetic Information Could Harbour Biomarkers of Diagnosis and Prognosis

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ